Nurse Practitioner, Adult Health · Pikeville, KY
NPI
1578836987
Since 2012
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
911 Bypass Rd Bldg A
Pikeville, KY, 41501
Phone (606) 430-2208
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
318 services
Medicare patients, 2024
99
Average age 68
Drug cost, 2024
$1.9M
4,055 prescriptions
Company payments, 2025
$730
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mavis Lowe was code 99214 (office e&m - established), 140 times for 76 patients. In total Mavis Lowe billed 318 services in 5 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 140 | 76 | $53.42 | $7,478 |
| 95251 Test - Miscellaneous | Facility | 105 | 55 | $20.57 | $2,160 |
| 99213 Office E&M - Established | Facility | 45 | 36 | $36.49 | $1,642 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 24 | 21 | $10.54 | $253 |
By year: 2022 $11K for 244 services; 2023 $12K for 264 services; 2024 $12K for 318 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mavis Lowe prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 398 prescriptions and refills. In total Mavis Lowe wrote 4,055 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 398 | 622 | 86 | $2,399 |
| Ozempic Semaglutide | 330 | 398 | 73 | $362K |
| Metformin Hcl Generic | 299 | 474 | 66 | $4,578 |
| Jardiance Empagliflozin | 278 | 364 | 54 | $207K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 230 | 379 | 80 | $15K |
| Levothyroxine Sodium Generic | 148 | 243 | 41 | $1,032 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 146 | 291 | 63 | $11K |
| Tresiba Flextouch U-200 Insulin Degludec | 139 | 196 | 34 | $225K |
| Novolog Flexpen Insulin Aspart | 135 | 161 | 46 | $25K |
| Tresiba Flextouch U-100 Insulin Degludec | 135 | 162 | 33 | $79K |
| Farxiga Dapagliflozin Propanediol | 131 | 175 | 27 | $94K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 127 | 192 | 43 | $20K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 94 | 107 | 16 | $101K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 79 | 97 | 19 | $80K |
| Mounjaro Tirzepatide | 77 | 91 | 20 | $95K |
Brand drugs: 2,390 claims; generic drugs: 943 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mavis Lowe $730 ($730 in general payments such as food, travel and fees) from 14 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $151.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $151 |
| Novo Nordisk Inc NVO | 8 | $139 |
| Dexcom, Inc. DXCM | 3 | $99.3 |
| Abbott Laboratories ABT | 5 | $82.31 |
| Beta Bionics, Inc. BBNX | 2 | $44.84 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $40.4 |
| Merck Sharp & Dohme LLC MRK | 2 | $40.36 |
| Merz Pharmaceuticals, LLC | 1 | $24.45 |
| Baxter Healthcare BAX | 1 | $23.79 |
| Corcept Therapeutics CORT | 1 | $18.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.